NEW YORK (GenomeWeb) – Fluidigm and GenomOncology announced today that they have partnered to create what they're calling the Immuno-Oncology Gene Expression Workflow, with the goal of accelerating the development of checkpoint immunotherapies and the identification of potential predictive biomarker signatures for therapeutic response.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.